Search Results 391-400 of 14896 for testosterone

  1. Flecainide (Oral Route) Side Effects - Mayo Clinic

    Rare · Arm, back, or jaw pain · black, tarry stools · bleeding gums · blood in the urine or stools · blurred vision · chest discomfort · chest tightness or heaviness ...

  2. Publications - Abhinav Khanna, M.D., M.P.H. - Mayo Clinic

    Testosterone Therapy after Radiation Therapy for Low, Intermediate and High Risk Prostate Cancer. J Urol. 2015 Nov; 194 (5):1271-6 Epub 2015 May 27. View ...

  3. SBRT for Oligometastatic Castration-Refractory Prostate Cancer - Mayo Clinic

    Castrate levels of testosterone; Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) ≤ 2 (Appendix I). Life expectancy > 6 months. Exclusion ...

  4. Methotrexate (Oral Route) Before Using - Mayo Clinic

    Testosterone; Tetracycline; Tiaprofenic Acid; Ticarcillin; Tigecycline; Tipranavir; Tizanidine; Tolazamide; Tolbutamide; Tolcapone; Tolfenamic Acid; Tolmetin ...

  5. A Study Using Gallium-68 PSMA-11 and C-11 Choline PET Imaging to Detect Metastatic Prostate Cancer in Patients - Mayo Clinic

    Total testosterone test measured within 30 days of PSMA PET. Exclusion Criteria: Undergoing (or within 4 months) investigational therapy for prostate cancer ...

  6. A Study to Compare Docetaxel/Prednisone to Docetaxel/Prednisone Combined with OGX-011 in Men with Prostate Cancer - Mayo Clinic

    Castrate serum testosterone level (< 50 ng/dL-or-< 1.7 nmol/L). Must be willing to continue primary androgen suppression with gonadotropin-releasing hormone ...

  7. Cancer Clinical Trials - Medical Professionals

    Abiraterone acetate may help fight prostate cancer by lowering the amount of testosterone made by the body. Apalutamide may help fight prostate cancer by ...

  8. Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET) - Mayo Clinic

    ... testosterone]. Taking no medications for the treatment of insulin resistance. Exclusion Criteria: Diagnosis of Cushing's syndrome; Untreated hypo ...

  9. Once-daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone. - Mayo Clinic

    Patients must have castrate levels of testosterone (<50 ng/dl [1.74 nmol/l]). Patients must have undergone orchiectomy, or have been on LHRH agonists or ...

  10. Premature ejaculation - Diagnosis and treatment - Mayo Clinic

    Understand what may cause ejaculation to happen earlier than wanted during sex. Also learn how to treat and prevent it.